Generally, they seek a treatment that is effective but does not disrupt their schedules too much
This includes individuals with: Diagnosed MASLD or MASH, where GLP-1 therapy may offer therapeutic benefits but requires monitoring Chronic viral hepatitis (hepatitis B or C), particularly if transaminases are elevated Autoimmune hepatitis or other inflammatory liver conditions Cirrhosis or advanced fibrosis, where specialist consultation may be appropriate despite generally not requiring dose adjustment History of drug-induced liver injury from other agents For these patients, baseline comprehensive liver assessmentincluding liver enzymes, synthetic function tests (albumin, INR), and potentially imaging or non-invasive fibrosis markers (such as FIB-4 or ELF)helps establish a reference point for monitoring treatment effects
P., Wei, W., Gauld, J
Managing reflux with antacids, dietary changes, or smaller meals frequently resolves this secondary cough
Concerns have emerged recently regarding the circulation of falsified Ozempic (semaglutide) pens in countries including Brazil, the United Kingdom, and the United States
GLP-1 medications help control blood sugar and induce weight loss acting like a natural hormone in the body called GLP-1